Douglas Joanne T, Rivera Angel A, Lyons Gray R, Lott Patricia F, Wang Dezhi, Zayzafoon Majd, Siegal Gene P, Cao Xu, Theiss Steven M
Division of Human Gene Therapy, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
J Spinal Disord Tech. 2010 Feb;23(1):63-73. doi: 10.1097/BSD.0b013e318193b693.
Ex vivo gene transfer for spinal fusion.
This study aimed to evaluate ex vivo transfer of the nuclear-localized Hoxc-8-interacting domain of Smad1 (termed Smad1C) to rabbit bone marrow stromal cells (BMSCs) by a tropism-modified human adenovirus serotype 5 (Ad5) vector as a novel therapeutic approach for spinal fusion.
Novel approaches are needed to improve the success of bone union after spinal fusion. One such approach is the ex vivo transfer of a gene encoding an osteoinductive factor to BMSCs which are subsequently reimplanted into the host. We have previously shown that heterologous expression of the Hoxc-8-interacting domain of Smad1 in the nuclei of osteoblast precursor cells is able to stimulate the expression of genes related to osteoblast differentiation and induce osteogenesis in vivo. Gene delivery vehicles based on human Ad5 are well suited for gene transfer for spinal fusion because they can mediate high-level, short-term gene expression. However, Ad5-based vectors with native tropism poorly transduce BMSCs, necessitating the use of vectors with modified tropism to achieve efficient gene transfer.
The gene encoding Smad1C was transferred to rabbit BMSCs by an Ad5 vector with native tropism or a vector retargeted to alphav integrins, which are abundantly expressed on rabbit BMSCs. Transduced BMSCs were maintained in osteoblastic differentiation medium for 30 days. Alkaline phosphatase activity was determined and cells stained for calcium deposition. As positive controls for osteogenesis, we used Ad5 vectors expressing bone morphogenetic protein 2. As negative controls, BMSCs were mock-transduced or transduced with an Ad5 vector expressing beta-galactosidase. In an immunocompetent rabbit model of spinal fusion, transduced BMSCs were coated onto absorbable gelatin sponge and implanted between decorticated transverse processes L6 and L7 of 8-week-old female New Zealand white rabbits. Animals were killed 4 weeks after implantation of the sponges, the fusion masses harvested and the area of new bone quantified using image analysis software.
The Smad1C-expressing tropism-modified Ad5 vector mediated a significantly higher level of alkaline phosphatase activity and calcium deposition in transduced rabbit BMSCs than all other vectors. The rabbit BMSCs transduced ex vivo with the Smad1C-expressing tropism-modified Ad5 vector mediated a greater amount of new bone formation than BMSCs transduced with any other vector.
Delivery of the Smad1C gene construct to BMSCs by an alphav integrin-targeted Ad5 vector shows promise for spinal fusion and other applications requiring the formation of new bone in vivo.
用于脊柱融合的体外基因转移。
本研究旨在评估通过嗜性修饰的人5型腺病毒(Ad5)载体将Smad1的核定位Hoxc-8相互作用结构域(称为Smad1C)体外转移至兔骨髓基质细胞(BMSC),作为脊柱融合的一种新型治疗方法。
需要新的方法来提高脊柱融合后骨愈合的成功率。一种这样的方法是将编码骨诱导因子的基因体外转移至BMSC,随后将其重新植入宿主。我们之前已经表明,Smad1的Hoxc-8相互作用结构域在成骨细胞前体细胞的细胞核中的异源表达能够刺激与成骨细胞分化相关的基因表达,并在体内诱导成骨。基于人Ad5的基因递送载体非常适合用于脊柱融合的基因转移,因为它们可以介导高水平的短期基因表达。然而,具有天然嗜性的基于Ad5的载体很难转导BMSC,因此需要使用具有修饰嗜性的载体来实现有效的基因转移。
通过具有天然嗜性的Ad5载体或重新靶向αv整合素(在兔BMSC上大量表达)的载体,将编码Smad1C的基因转移至兔BMSC。转导的BMSC在成骨细胞分化培养基中培养30天。测定碱性磷酸酶活性,并对细胞进行钙沉积染色。作为成骨的阳性对照,我们使用表达骨形态发生蛋白2的Ad5载体。作为阴性对照,BMSC进行模拟转导或用表达β-半乳糖苷酶的Ad5载体转导。在具有免疫活性的兔脊柱融合模型中,将转导的BMSC包被在可吸收明胶海绵上,并植入8周龄雌性新西兰白兔的L6和L7去皮质横突之间。在植入海绵4周后处死动物,收获融合块,并用图像分析软件对新骨面积进行定量。
表达Smad1C的嗜性修饰Ad5载体介导转导的兔BMSC中的碱性磷酸酶活性和钙沉积水平显著高于所有其他载体。用表达Smad1C的嗜性修饰Ad5载体体外转导的兔BMSC介导的新骨形成量比用任何其他载体转导的BMSC都多。
通过靶向αv整合素的Ad5载体将Smad1C基因构建体递送至BMSC,在脊柱融合和其他需要在体内形成新骨的应用中显示出前景。